These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 39001731)

  • 1. Prognostic Value of Left Ventricular
    Clerc OF; Datar Y; Cuddy SAM; Bianchi G; Taylor A; Benz DC; Robertson M; Kijewski MF; Jerosch-Herold M; Kwong RY; Ruberg FL; Liao R; Di Carli MF; Falk RH; Dorbala S
    JACC Cardiovasc Imaging; 2024 Aug; 17(8):911-922. PubMed ID: 39001731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Left Ventricular
    Clerc OF; Datar Y; Cuddy SA; Bianchi G; Taylor A; Benz DC; Robertson M; Kijewski MF; Jerosch-Herold M; Kwong RY; Ruberg FL; Liao R; Di Carli MF; Falk RH; Dorbala S
    medRxiv; 2023 Sep; ():. PubMed ID: 37745589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of right ventricular amyloid burden with 18F-florbetapir positron emission tomography/computed tomography and its association with right ventricular dysfunction and outcomes in light-chain amyloidosis.
    Datar Y; Clerc OF; Cuddy SAM; Kim S; Taylor A; Neri JC; Benz DC; Bianchi G; Yee AJ; Sanchorawala V; Ruberg FL; Landau H; Liao R; Kijewski MF; Jerosch-Herold M; Kwong RY; Di Carli MF; Falk RH; Dorbala S
    Eur Heart J Cardiovasc Imaging; 2024 Apr; 25(5):687-697. PubMed ID: 38193678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?
    Cuddy SAM; Bravo PE; Falk RH; El-Sady S; Kijewski MF; Park MA; Ruberg FL; Sanchorawala V; Landau H; Yee AJ; Bianchi G; Di Carli MF; Cheng SC; Jerosch-Herold M; Kwong RY; Liao R; Dorbala S
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1325-1336. PubMed ID: 32417333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linking Amyloid Burden to Prognosis:
    Masri A
    JACC Cardiovasc Imaging; 2024 Aug; 17(8):923-925. PubMed ID: 39023497
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiac Amyloid Quantification Using 
    Clerc OF; Cuddy SAM; Robertson M; Vijayakumar S; Neri JC; Chemburkar V; Kijewski MF; Di Carli MF; Bianchi G; Falk RH; Dorbala S
    JACC Cardiovasc Imaging; 2023 Nov; 16(11):1419-1432. PubMed ID: 37676210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative Apical Sparing of Myocardial Longitudinal Strain Is Explained by Regional Differences in Total Amyloid Mass Rather Than the Proportion of Amyloid Deposits.
    Bravo PE; Fujikura K; Kijewski MF; Jerosch-Herold M; Jacob S; El-Sady MS; Sticka W; Dubey S; Belanger A; Park MA; Di Carli MF; Kwong RY; Falk RH; Dorbala S
    JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1165-1173. PubMed ID: 30121266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study.
    Park MA; Padera RF; Belanger A; Dubey S; Hwang DH; Veeranna V; Falk RH; Di Carli MF; Dorbala S
    Circ Cardiovasc Imaging; 2015 Aug; 8(8):. PubMed ID: 26259579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Detection of Multiorgan Light-Chain Amyloidosis by Whole-Body
    Ehman EC; El-Sady MS; Kijewski MF; Khor YM; Jacob S; Ruberg FL; Sanchorawala V; Landau H; Yee AJ; Bianchi G; Di Carli MF; Falk RH; Hyun H; Dorbala S
    J Nucl Med; 2019 Sep; 60(9):1234-1239. PubMed ID: 30954943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study demonstrating cardiac uptake with 18F-florbetapir PET in AL amyloidosis patients with cardiac involvement.
    Manwani R; Page J; Lane T; Burniston M; Skillen A; Lachmann HJ; Gillmore JD; Fontana M; Whelan C; Hawkins PN; Wagner T; Wechalekar AD
    Amyloid; 2018 Dec; 25(4):247-252. PubMed ID: 30661419
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantitative [
    Khor YM; Cuddy S; Harms HJ; Kijewski MF; Park MA; Robertson M; Hyun H; Di Carli MF; Bianchi G; Landau H; Yee A; Sanchorawala V; Ruberg FL; Liao R; Berk J; Falk RH; Dorbala S
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1998-2009. PubMed ID: 31807884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.
    Barros-Gomes S; Williams B; Nhola LF; Grogan M; Maalouf JF; Dispenzieri A; Pellikka PA; Villarraga HR
    JACC Cardiovasc Imaging; 2017 Apr; 10(4):398-407. PubMed ID: 27639764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of cardiac involvement and survival in patients with primary systemic light-chain amyloidosis: roles of the clinical, chemical, and 3-D speckle tracking echocardiography parameters.
    Lei C; Zhu X; Hsi DH; Wang J; Zuo L; Ta S; Yang Q; Xu L; Zhao X; Wang Y; Sun S; Liu L
    BMC Cardiovasc Disord; 2021 Jan; 21(1):43. PubMed ID: 33478398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging cardiac amyloidosis: a pilot study using ¹⁸F-florbetapir positron emission tomography.
    Dorbala S; Vangala D; Semer J; Strader C; Bruyere JR; Di Carli MF; Moore SC; Falk RH
    Eur J Nucl Med Mol Imaging; 2014 Sep; 41(9):1652-62. PubMed ID: 24841414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent Prognostic Utility of
    Choi YJ; Koh Y; Lee HJ; Hwang IC; Park JB; Yoon YE; Kim HL; Kim HK; Kim YJ; Cho GY; Sohn DW; Paeng JC; Lee SP
    J Nucl Med; 2022 Jul; 63(7):1064-1069. PubMed ID: 34916248
    [No Abstract]   [Full Text] [Related]  

  • 16. Feasibility of
    Wang X; Guo Y; Gao Y; Ren C; Huang Z; Liu B; Li X; Chang L; Shen K; Ding H; Zhang H; Tian Z; Hacker M; Zhang S; Wang Y; Li J; Li X; Huo L
    JACC Cardiovasc Imaging; 2022 Nov; 15(11):1960-1970. PubMed ID: 36357138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracardiac
    Wagner T; Page J; Burniston M; Skillen A; Ross JC; Manwani R; McCool D; Hawkins PN; Wechalekar AD
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1129-1138. PubMed ID: 29651545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18 F-Florbetapir PET/CT and 68 Ga-FAPI PET/CT in a Case of Light Chain Amyloidosis With Predominant Multiple Tumor-Like Deposits.
    Zhang Y; Wang X; Ren C; Shen K; Huo L
    Clin Nucl Med; 2024 May; 49(5):486-488. PubMed ID: 38465960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis.
    Palladini G; Campana C; Klersy C; Balduini A; Vadacca G; Perfetti V; Perlini S; Obici L; Ascari E; d'Eril GM; Moratti R; Merlini G
    Circulation; 2003 May; 107(19):2440-5. PubMed ID: 12719281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of the
    Mestre-Torres J; Lorenzo-Bosquet C; Cuberas-Borrós G; Gironella M; Solans-Laque R; Fernández-Codina A; Bujan-Rivas S; Castell-Conesa J; Martínez-Valle F
    Amyloid; 2018 Jun; 25(2):109-114. PubMed ID: 29706127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.